Institute for International Research

• Review examples of collaborative industry efforts in sharing information to make earlier go/no go decisions
• Understand drug label expectations depending on severity of QT prolongation
• Develop strategies for integrating biomarkers into the clinical development program through industry case studies
• Overcome challenges in trial design by examining the successes and failures of past trials • Predict the viability of compounds using modeling and simulation approaches
• Uncover the latest information about the progress of the Critical Path Initiative
• Identify the current processes and future directions of translational medicine
• Strengthen risk management tools using case studies from a CRO's perspective
• Weigh the value of using microdosing in early clinical trials

Including Presentations on the Following Topics

• The Critical Path Initiative (CPI)
• Regulatory Framework Abroad
•  Challenges in Microdosing
• Working with IRBs
• Exploratory INDs
• Clinical Trial Optimization

AND MORE!